Healthcare stocks were the poorest performers during afternoon trading on Thursday, increasing by 0.2%. Among the stocks in the sector, Moderna Inc (MRNA) and Agilent Technologies, Inc…
Thursday’s worst performing sectors were healthcare and utilities. Read More »
During afternoon trading on Thursday, Healthcare stocks are the sector with the lowest performance, with a slight increase of 0.2%. Specifically, Moderna Inc (MRNA) and Agilent Technologies, Inc. are leading within this sector.
Thursday’s underperforming sectors were healthcare and utilities. Read More »
Equities moved higher on Wednesday with a rebound in AI sentiment leading to Tech. and Nasdaq outperformance. For the day, the Nasdaq composite led the major US indices higher adding 2.17% while the S&P 500 gained 1.07 while the Dow brought up the rear advancing 0.31%. At the sector level, Tech shares paced gains up
ETFsector.com Daily Trading Outlook, September 12, 2024 Read More »
DEADLINE ALERT: Faruqi & Faruqi, LLP is conducting an investigation on behalf of Moderna investors.
Faruqi & Faruqi, LLP is investigating claims on behalf of investors of Moderna. Read More »
The transcript of Moderna, Inc.’s presentation at the Jefferies 2024 Global Healthcare Conference is discussed.
Solar energy becoming more affordable can lead to various possibilities. Dominion Energy has heavily restricted new solar initiatives in Virginia.
Saturday links discussing what is functioning well. Read More »
Moderna, Inc. participated in Bernstein’s 40th Annual Strategic Decisions Conference and the transcript of the event is available.
Read More: https://www.benzinga.com/markets/equities/24/05/39077289/cathie-wood-ledark-invest-cuts-robinhood-holdings-amid-bitcoin-dip-keeps-selling-moderna-stock-b?utm_source=TechInvestorNews&utm_campaign=partner_feed&utm_medium=partner_feed&utm_content=site
Investigating the obstacles that could impede Moderna Inc’s market performance.
Advancements made by Moderna in developing a cancer vaccine…
Aggressive Progress Made by Moderna in Developing Cancer Vaccine Read More »
Stay updated with the latests analysis and insights fromm etfsector.com
